Genzyme patents expiration
1. Mozobil patents expiration
MOZOBIL's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7897590 | GENZYME | Methods to mobilize progenitor/stem cells |
Jul, 2023
(2 months ago) | |
| US6987102 | GENZYME | Methods to mobilize progenitor/stem cells |
Jul, 2023
(2 months ago) | |
Drugs and Companies using PLERIXAFOR ingredient
Market Authorisation Date: 15 December, 2008
Treatment: Use in combination with granulocyte-colony stimulating factor (g-csf) to mobilize hematopoietic stem cells to peripheral blood for collection & subsequent autologous transplantation in patients with n...
Dosage: SOLUTION;SUBCUTANEOUS
How can I launch a generic of MOZOBIL before it's drug patent expiration?
More Information on Dosage
MOZOBIL family patents
2. Renvela patents expiration
RENVELA's oppositions filed in EPO
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US9095509 | GENZYME | Sachet formulation for amine polymers |
Dec, 2030
(7 years from now) | |
Drugs and Companies using SEVELAMER CARBONATE ingredient
Market Authorisation Date: 18 February, 2009
Treatment: NA
Dosage: FOR SUSPENSION;ORAL
How can I launch a generic of RENVELA before it's drug patent expiration?
More Information on Dosage
RENVELA family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic